Biotechnology from bench to business

• Follow GEN on:
• Login | Register | Subscribe

• ADME/Tox
• Automation
• Bioprocess Scale-Up
• Bioreactors
• Biosimilars
• Cell Culture
• Cell-Based Assays
• Contract Manufacturing
• Gene Therapy
• High-Throughput Screening
• Immunoassay
• Induced Pluripotent Stem Cells
• Informatics
• Liquid Handling
• Protein Characterization
• Protein Detection
• Regenerative Medicine
• RNAi/siRNA
• Stem Cells
• Western Blot

• GEN Articles

• More »

• Assay Tutorials: High-Content Cytotoxicity Analysis
  Methodology Detects and Quantitates Multiparametric Data from Individual Cells
• Feature Articles: Q&A: Life Technologies Formed from AB/Invitrogen
  President and COO of Applied Biosystems Answers GEN's Questions about the Merger
• Tutorials: Inducement of Gene Expression or Silencing
  Technology Rearranges and Adds Vector Elements to Enhance Transfection
• Tutorials: Aiming at Easier Scale-Up in Protein Production
  Evaluation of Invitrogen’s FreeStyle™ - MAX CHO Expression System

• GEN News Highlights

• More »

• UC San Diego and Salk Institute to Conduct Cell Transplant Research for ALS with $11.5M
  
• Invitrogen and Applied Biosystems to Be Called Life Technologies
  
• Invitrogen Ponies Up $6.7B for Applied Biosystems
  

• New Products

• More »

OZ Biosciences Transfection Reagents Designed to transfect primary and hard-to-transfect cells, Magnetofectamine™ is the combination of Lipofectamine™ 2000, a transfection reagent from Life Technologies (Invitrogen™) for nucleic acid delivery (DNA and siRNA), with the Magnetofection™